Megestrol for weight loss in stomach cancer before surgery
Part of Cancer, Digestive system clinical trials.
This trial tests whether a medicine called megestrol acetate (an appetite stimulant) can help patients with stomach cancer who have lost weight (cachexia). The study combines this with standard chemotherapy and immunotherapy before surgery, aiming to improve nutrition and overall outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have stage III stomach or gastroesophageal junction cancer that can be surgically removed.
- You need to have cachexia (unexplained weight loss, low body mass, or muscle wasting).
- You should not have had any previous cancer treatment for this condition.
- You must be willing to undergo surgery to remove the tumor.
- You need to be between 18 and 80 years old and in relatively good health (able to do daily activities).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a combination of three medicines—an immunotherapy (anti-PD-1), an immune booster (thymalfasin), and a chemotherapy regimen (SOX)—given before surgery to shrink stage III stomach or gastroesophageal junction cancer and improve outcomes.
This trial tests whether adding two drugs (mecapegfilgrastim and adebrelimab) to standard chemotherapy before surgery can help treat advanced stomach or gastroesophageal junction cancer that has not yet spread. The goal is to shrink the tumor and improve surgical outcomes.
This study tests combining an immunotherapy drug (PD-1 inhibitor) and a medication to boost your immune system (thymalfasin) with standard chemotherapy and radiation before surgery for stage III cancer where the stomach meets the esophagus. The goal is to see if this approach can shrink the tumor and improve outcomes.
This trial tests if taking megestrol acetate (a medicine used to stimulate appetite and help gain weight) can reduce weight loss caused by chemotherapy in people with locally advanced colorectal cancer. It may help you maintain strength and energy during treatment.
This study tests a special form of megestrol acetate (a medicine that can help with appetite and weight gain) in people with advanced digestive system cancers who are about to start or are already taking a type of targeted therapy called a TKI. The goal is to see if it helps with cancer-related weight loss and wasting (cachexia).
This study tests a new approach for people with advanced stomach or esophageal cancer who are losing weight and appetite. It combines a special form of a medicine (megestrol acetate) with standard chemotherapy and immunotherapy to see if it helps improve eating, weight, and quality of life.
Hear when a new Stage III Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.